CA2305183A1 - Traitement post-chirurgical a l'aide de dichloroacetate - Google Patents

Traitement post-chirurgical a l'aide de dichloroacetate Download PDF

Info

Publication number
CA2305183A1
CA2305183A1 CA002305183A CA2305183A CA2305183A1 CA 2305183 A1 CA2305183 A1 CA 2305183A1 CA 002305183 A CA002305183 A CA 002305183A CA 2305183 A CA2305183 A CA 2305183A CA 2305183 A1 CA2305183 A1 CA 2305183A1
Authority
CA
Canada
Prior art keywords
dichloroacetate
treatment
postsurgical
postsurgical treatment
permitting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002305183A
Other languages
English (en)
Other versions
CA2305183C (fr
Inventor
Gary Lopaschuk
Ruth Collins-Nakai
Koon Teo
Jason R.B. Dyck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
The Governors Of The University Of Alberta
Gary Lopaschuk
Ruth Collins-Nakai
Koon Teo
Jason R.B. Dyck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Governors Of The University Of Alberta, Gary Lopaschuk, Ruth Collins-Nakai, Koon Teo, Jason R.B. Dyck filed Critical The Governors Of The University Of Alberta
Publication of CA2305183A1 publication Critical patent/CA2305183A1/fr
Application granted granted Critical
Publication of CA2305183C publication Critical patent/CA2305183C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
CA002305183A 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate Expired - Fee Related CA2305183C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6091297P 1997-10-03 1997-10-03
US60/060,912 1997-10-03
PCT/US1998/020394 WO1999017763A1 (fr) 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate

Publications (2)

Publication Number Publication Date
CA2305183A1 true CA2305183A1 (fr) 1999-04-15
CA2305183C CA2305183C (fr) 2008-09-23

Family

ID=22032515

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002305183A Expired - Fee Related CA2305183C (fr) 1997-10-03 1998-09-30 Traitement post-chirurgical a l'aide de dichloroacetate

Country Status (4)

Country Link
JP (1) JP2001523635A (fr)
AU (1) AU9590698A (fr)
CA (1) CA2305183C (fr)
WO (1) WO1999017763A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063446A1 (fr) * 2004-12-15 2006-06-22 The Governors Of The University Of Alberta Procedes de cardioprotection utilisant le dichloroacetate en combinaison avec un inotrope

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727284B2 (en) 1997-10-03 2004-04-27 University Of Alberta Postsurgical treatment with dichloroacetate
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1908462A3 (fr) * 2002-06-20 2008-06-25 The Governors Of The University Of Alberta Dichloroacetate en combinaison avec des medicaments cardioprotecteurs ou hemodynamiques
US20040039055A1 (en) * 2002-06-20 2004-02-26 Lopaschuk Gary D. Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs
US6693133B1 (en) 2002-10-07 2004-02-17 University Of Alberta Methods of cardioprotection using dichloroacetate in combination with an inotrope
CA2489853A1 (fr) * 2004-01-16 2005-07-16 The Governors Of The University Of Alberta Methodes de cardioprotection au moyen de dichloroacetate en combinaison avec un inotrope
WO2011159658A2 (fr) 2010-06-14 2011-12-22 University Of Florida Research Foundation, Inc. Procédés, dosages et kits impliquant le dichloroacétate (dca)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786993B1 (fr) * 1994-10-17 2002-06-05 Peter W. Stacpoole Compositions comprenant de l'acide dichloroacetique tamponne au carbonate/bicarbonate et leur utilisation dans le traitement de troubles metaboliques et cardiovasculaires
US5587397A (en) * 1995-06-08 1996-12-24 Cypros Pharmaceutical Corporation Reduction of elevated blood lactate using twice-daily dichloroacetate

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006063446A1 (fr) * 2004-12-15 2006-06-22 The Governors Of The University Of Alberta Procedes de cardioprotection utilisant le dichloroacetate en combinaison avec un inotrope
WO2007030944A2 (fr) * 2005-09-16 2007-03-22 The Governors Of The University Of Alberta Methodes de cardioprotection consistant a utiliser du dichloroacetate combine a un inotrope
WO2007030944A3 (fr) * 2005-09-16 2007-05-03 Univ Alberta Methodes de cardioprotection consistant a utiliser du dichloroacetate combine a un inotrope

Also Published As

Publication number Publication date
JP2001523635A (ja) 2001-11-27
WO1999017763A1 (fr) 1999-04-15
AU9590698A (en) 1999-04-27
CA2305183C (fr) 2008-09-23

Similar Documents

Publication Publication Date Title
CA2231803A1 (fr) Extrait lipidique possedant une activite anti-inflammatoire
CA2294927A1 (fr) Dispositif et procede d'ablation circonferentielle
CA2189658A1 (fr) Formes galeniques a liberation controlee de l'azithromycine
CA2400801A1 (fr) Traitement de l'insuffisance cardiaque congestive au moyen de sang autologue pretraite
AU3112899A (en) Rf diathermy and faradic muscle stimulation treatment
CA2058179A1 (fr) Systeme et methode de conditionnement electrophysiologique de base
AU3372895A (en) Therapeutic food composition and method to diminish blood sugar fluctuations
CA2181568A1 (fr) Utilisation de l'interleukine-12 pour prevenir la reaction du greffon contre l'hote
CA2121484A1 (fr) Traitement de l'acne ou de la pseudo-folliculite de la barbe
CA2294921A1 (fr) Levobupivacine et son utilisation
AU4777896A (en) Use of low dose amount of spironolactone for treatment of cardiovascular disease
AU2463099A (en) Gabapentin and its derivatives for the treatment of muscular and skeletal pain
AU9598198A (en) Method and apparatus for improving human physical performance, training for athletic activities, preventing injury, physical therapy or the like
CA2305183A1 (fr) Traitement post-chirurgical a l'aide de dichloroacetate
CA2290482A1 (fr) Composition contenant du fructosane pour la prevention et le traitement du cancer du colon et procede preventif et therapeutique du cancer du colon
AU1376497A (en) Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness
EP1304108A3 (fr) Compositions pour traiter l'arythmie et procédés de traitement
AU2229695A (en) Cardiac pacemaker with physiological control and method
CA2091134A1 (fr) Agent therapeutique contre les risques d'avortement
EP1736170A3 (fr) Agent pour le traitement de condition allergique ou hypersensitive
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
FR2687179B1 (fr) L'arc, la voute, la croisee d'arcs et la coupole destines a etre habites et a l'activite humaine.
AU1413997A (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
EP0668771A4 (fr) Traitement des maladies autoimmunes par induction d'une tolerance des cellules, des tissus et des organes.
CA2167926A1 (fr) Utilisation de benzydamine pour le traitement d'un etat pathologique cause par le tnf

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed